Tone mix
Week by week 52 weeks
Share of Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s 85 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Nov 24, 2025 · tone -99FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder - Takeda Pharmaceutical Co (NYSE:TAK)-123
- Week of Jun 1, 2026 · tone -99Is Takeda Pharmaceutical Company Limited (TAK) Facing Major Legal Risk After U.S. Jury Rules on Generic Drug Delay?-111
- Week of Dec 15, 2025 · tone +100Takeda posts trial win for plaque psoriasis pill (TAK:NYSE)+100
- Week of Feb 23, 2026 · tone -93Takeda Shares Down After Entyvio Shows Strong Results In Ulcerative Colitis Trial In Children - Takeda Pharmaceutical Co (NYSE:TAK)-99
- Week of May 18, 2026 · tone -50Jury Hits Takeda With $885 Million Antitrust Verdict - Takeda Pharmaceutical Co (NYSE:TAK)-99
- Week of Oct 27, 2025 · tone -50Takeda Lowers 2025 Outlook After Weak Q2 And Pipeline Impairment Charges - Takeda Pharmaceutical Co (NYSE:TAK)-91
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 3 | 0 |
| Last 30 sessions | 10 | 0 |
| Last 90 sessions | 30 | +7 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, October 30, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.fool.com · 1 outletTakeda (TAK) Q2 2026 Earnings Call TranscriptNeutral
- seekingalpha.com · 1 outletTakeda outlines JPY 1.19T FY 2026 core operating profit forecast while targeting early November U.S. ORZEYFUL launch (NYSE:TAK)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Takeda (TAK) Q2 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
| Takeda outlines JPY 1.19T FY 2026 core operating profit forecast while targeting early November U.S. ORZEYFUL launch (NYSE:TAK) | seekingalpha.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 29, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.finanznachrichten.de · 1 outletTakeda Pharmaceutical Company Limited: Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline MilestonesNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Takeda Pharmaceutical Company Limited: Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones | www.finanznachrichten.de | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletTakeda Pharmaceutical (TAK) Expected to Post Earnings on ThursdayNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Takeda Pharmaceutical (TAK) Expected to Post Earnings on Thursday | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletAddex Therapeutics (NASDAQ:ADXN) & Takeda Pharmaceutical (NYSE:TAK) Head-To-Head AnalysisNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Addex Therapeutics (NASDAQ:ADXN) & Takeda Pharmaceutical (NYSE:TAK) Head-To-Head Analysis | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletTakeda Pharmaceutical Co. $TAK Stock Purchased by Quadrant Capital Group LLCNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Takeda Pharmaceutical Co. $TAK Stock Purchased by Quadrant Capital Group LLC | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock), not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.